Loading...
Health

U. study: Pregnant women with severe COVID-19 symptoms at higher risk for complications, death – KSL.com

SALT LAKE CITY — Pregnant women who developed severe symptoms of COVID-19 were at higher risk of pregnancy complications and even death compared to women who experienced no symptoms, or mild or moderate symptoms, according to a new study led by a University of Utah researcher.

The good news, according to the study, is that most pregnant women who were studied didn’t experience severe or critical effects of COVID-19; however, Dr. Torri Metz, an associate professor and maternal-fetal medicine subspecialist at University of Utah Health, and the study’s lead author, said it’s still difficult to know why some pregnant women developed severe symptoms while others didn’t.

“(Adverse effects) do seem to be predominately limited to that severe and critical group but we don’t have control over who ends up being in that severe and critical group,” she said, in a briefing with media Friday. “And since that was 12% of our population, I think we have to take that into context to know that if pregnant women do develop COVID-19, they are at risk for developing severe and critical illness. And if they do, they are at risk for adverse pregnancy outcomes.”

The study was released Friday in time to be presented at the Society for Maternal-Fetal Medicine’s annual meeting. Researchers analyzed data from more than 1,200 pregnant women at 33 hospitals across 14 states from March 1 through July 31, 2020.

In all, nearly half were asymptomatic, while 27% reported mild symptoms and 14% experienced moderate symptoms. Another 8% experienced severe symptoms and 4% experienced critical symptoms.

Those who tended to experience worse symptoms were older, had higher body mass index, and were more likely to have underlying health conditions like asthma, diabetes or high blood pressure, researchers discovered. The women more likely to suffer severe outcomes from the coronavirus were more likely to die or have serious complications like preterm birth, postpartum hemorrhage or heavy bleeding after childbirth, high blood pressure during pregnancy, or have a cesarean delivery.

The death rate from the study of COVID-19 in women was also 0.3%, which would equate to 3 deaths per 1,000 or 300 per 100,000. The last known rate of 17.4 deaths per 100,000 in pregnant women without COVID-19, according to the Centers for Disease Control and Prevention.

“This is much higher than would be expected at baseline and it’s certainly concerning,” Metz said. “In pregnancy, we’re seeing the same thing that we’re seeing in non-pregnant people in that there are increased death rates over this time period.”

The data on higher deaths tied to COVID-19 is something that Metz’s University of Utah Health colleagues mentioned during a briefing Thursday. During that briefing, experts said COVID-19 was the third-leading cause of death in Utah during 2020 behind heart disease and cancer. It even outpaced heart disease and cancer at points during the end of the year.

The researchers were “in some ways” surprised by the findings. Metz explained that they weren’t sure if there were adverse pregnancy outcomes with COVID-19 when they began the study. They also didn’t know if those would be influenced by the severity of the disease.

There were some limitations to the study as well. She added a “vast majority” of the patients studied were in the third trimester of their pregnancy. Researchers still don’t know if infection in the first trimester would cause birth defects.

Metz said the study could be viewed as reassuring for women who experience mild or moderate COVID-19 symptoms, which was the majority of those who experienced any symptoms. That said, since there is no way of knowing someone’s outcome in advance, she advised that pregnant women wear a mask, practice social distancing and follow all other public health measures aimed at reducing the risk of contracting COVID-19.

Advice for COVID-19 vaccination during pregnancy

Pregnant women weren’t included during the initial COVID-19 vaccine trials. Pfizer is currently in the process of studying the vaccine in pregnant women but those trials aren’t yet completed. At this point in the vaccine rollout, pregnant medical professionals, emergency response or teachers would be among the individuals who would have to make the decision about vaccination.

The CDC’s official stance on the matter is that those who are pregnant should consult their health care provider since there are no data on the subject. It added there are no indications of risk from mRNA vaccine studies.

“When making a decision, pregnant people and their health care providers should consider the level of COVID-19 community transmission, the patient’s personal risk of contracting COVID-19, the risks of COVID-19 to the patient and potential risks to the fetus, the efficacy of the vaccine, the side effects of the vaccine, and the lack of data about the vaccine during pregnancy,” the CDC advises.

While the study didn’t address vaccines, Metz said knowing the risks of COVID-19 illness is something that women have to weigh in the decision over having a child during the pandemic, and if they want to get a COVID-19 vaccine.

This story will be updated.

Carter Williams

More stories you may be interested in

Leave a Reply

Your email address will not be published. Required fields are marked *